Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
about
Roadmap to a Comprehensive Clinical Data Warehouse for Precision Medicine Applications in OncologyBarriers preventing the adoption of comprehensive cancer genomic profiling in the clinic.Implementation and utilization of the molecular tumor board to guide precision medicine.Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.Molecular Tumor Boards: Current Practice and Future Needs.Molecular Tumor Boards: Realizing Precision Oncology Therapy.Recent advances in genomic profiling of adenosquamous carcinoma of the pancreas.PRECISION ONCOLOGY DECISION SUPPORT: CURRENT APPROACHES AND STRATEGIES FOR THE FUTURE.Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens.Clinical validation of the Tempus xO assay.RET rearrangements are actionable alterations in breast cancer
P2860
Q30352887-11301CA2-0489-4C29-94E0-D5CD19595E85Q39237394-B495AF07-1E71-4D28-8770-98F81988B724Q41339458-3298F7B3-194C-4B79-9C18-B5FCAB6A73FAQ41571663-DF249D69-44A0-4A54-9BA8-90D40CF27ECBQ42697732-99D56F77-873D-4533-9785-16AC1E860294Q46149223-EABE8331-6610-48AE-90F0-29FDAA280399Q48224260-B9EF8B41-5CB2-4C3F-96DB-97C3F256778BQ50115884-E9AD7E7F-3DC0-4109-B177-3740685C973FQ52573507-1837D766-37F1-4F24-98E6-8A5AB19EBF1AQ55091748-1FB30F88-F20B-4153-9382-6C1E0D8A139BQ59136613-F4E43506-1529-44FC-84D2-29B198997EAA
P2860
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical Actionability of Comp ...... of Rare or Refractory Cancers.
@en
Clinical Actionability of Comp ...... of Rare or Refractory Cancers.
@nl
type
label
Clinical Actionability of Comp ...... of Rare or Refractory Cancers.
@en
Clinical Actionability of Comp ...... of Rare or Refractory Cancers.
@nl
prefLabel
Clinical Actionability of Comp ...... of Rare or Refractory Cancers.
@en
Clinical Actionability of Comp ...... of Rare or Refractory Cancers.
@nl
P2093
P2860
P1433
P1476
Clinical Actionability of Comp ...... of Rare or Refractory Cancers.
@en
P2093
Alexei Vazquez
Antoinette R Tan
Chang S Chan
David Foran
Denis Tolkunov
Elizabeth Poplin
Howard Kaufman
James X Sun
P2860
P356
10.1634/THEONCOLOGIST.2016-0049
P577
2016-08-26T00:00:00Z